TrialThe oncologist2018

Single Arm, Phase II Study of Cisplatin, Docetaxel, and Erlotinib in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas.

William N William et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.